Anti-TNF agents had been administered before the diagnosis of TB in 0.13% of patients with TB; the anti-TNF agents used were adalimumab (n = 147, 44.4%), infliximab (n = 123, 55.4%), and etanercept (n = 85, 34.0%). Here, TNF is linked to tuberculosis.